Completeness of safety reporting in randomized trials: An evaluation of 7 medical areas

JAMA

Volumn 285, Issue 4, 2001, Pages 437-443

  Ioannidis, John P A ^a,b   Lau, Joseph ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0035941525     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.4.437     Document Type: Article

References (22)

1. Statistical problems in the reporting of clinical trials: A survey of three medical journals
2. Improving the quality of reporting of randomized controlled trials: The CONSORT statement
3. Checklist of information for inclusion in reports of clinical trials
4. Reporting of data from randomized trials
5. Confidence intervals for a binomial proportion
6. The relationship between study design, results, and reporting of randomized trials of HIV infection
7. Cumulative meta-analysis of therapeutic trials for myocardial infarction
8. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care
9. Drug treatment of hypertension in the elderly: A meta-anaiysis
10. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: A meta-regression analysis of randomized, controlled trials
11. Indications for treatment of Helicobacter pylori infection: A systematic overview
12. Meta-analyses of randomised controlled trials of selective decontamination of the digestive tract
13. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit
14. Sensitivity of effect variables in rheumatoid arthritis: A meta-analysis of 130 placebo controlled NSAID trials
15. Institute for Scientific Information
16. Reporting of adverse effects in clinical trials should be improved: Lessons from acute postoperative pain
17. Identification of adverse reactions to new drugs, II: How were 18 important adverse reactions discovered and with what delays?
18. Introducing MedWatch: A new approach to reporting medication and device adverse effects and product problems
19. Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy